PharmGen Science, Inc. (004720.KS) KSC

4,055.00

-105(-2.52%)

Updated at October 17 03:30PM

Currency In KRW

Valuation

Market Cap74.18B
Enterprise Value75.25B
P/E Ratio25.1
PEG Ratio0.01
Price/Sales Ratio0.43
Price/Book Ratio0.3
Enterprise/Revenue0.47
Enterprise/EBITDA9.14

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.02
Operating Margin0.06

Management Effectiveness

Return On Assets0.01
Return On Equity0.01

Income Statement

Revenue171.29B
Revenue/Share9,633.77
Gross Profit108.03B
EBITDA10.79B
Net Income2.79B
Diluted EPS152.25

Balance Sheet

Total Cash13.18B
Total Cash/Share727.28
Total Debt19.09B
Total Debt/Equity0.08
Current Ratio2.14
Book Value Per Share13,537.15

Price History

52-Week Change-16.91
52-Week High5,490
52-Week Low3,640
Moving Average 50 Days4,424.7
Moving Average 200 Days4,303.4

Statistics

Average Volume428,704
Shares Outstanding18.47M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateDecember 09, 2014